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Abstract
Introduction: We aimed to compare the outcomes of robotic lapa-
roendoscopic single-site living donor nephrectomy (R-LESS LDN) 
vs. standard laparoscopic living donor nephrectomy (LLDN).
Methods: Between October 2013 and November 2015, 39 patients 
were allocated to either standard LLDN (n=25) or R-LESS LDN 
(n=14). Patient demographics, perioperative outcomes, analgesic 
requirement, visual analogue scale of pain at postoperative days 1, 
3, 7, and 30, and a health-related quality of life and body image 
questionnaire were prospectively collected. 
Results: There were no significant differences in demographics 
and intraoperative outcomes between the two cohorts. The R-LESS 
LDN cohort had lower analgesic requirement (p=0.002) and lower 
visual pain scores on days 1 and 3 (p=0.001). Additionally, body 
image and satisfaction scores in the R-LESS group were also supe-
rior compared to the LLDN cohort (p=0.008). There was no sig-
nificant difference in the postoperative complications according 
to the Clavien-Dindo system. Recipient graft functional outcomes 
were equivalent.
Conclusions: This is the first evidence that R-LESS LDN is safe and 
associated with comparable surgical and early functional outcomes 
compared to LLDN, while pain, donor body image, and satisfaction 
scores were improved compared to LLDN. 
Introduction
Kidney transplantation is the preferred option for patients 
with end-stage renal disease. However, due to shortage of 
donor organs, we turn to living donor kidney transplants, 
which provide better graft function and survival compared 
to organs from deceased donors.1,2 Historically, living donor 
nephrectomy (LDN) had been performed as an open tech-
nique, which brought significant comorbidity and impacted 
donor quality of life. Over the last two decades, surgical 
practices have developed with the aim of improving postop-
erative donor recovery, while maintaining surgical quality; 
these modifications to the donor operation have included 
mini-incision muscle-splitting open LDN through a dorsal 
lumbotomy,3 to minimally invasive techniques, including 
standard laparoscopy,4 hand-assisted laparoscopy,5 and ret-
roperitoneoscopy.6 The advent of laparoscopic LDN was not 
only associated with a significant rise in the number of liv-
ing donors globally, but also had a major impact on patient 
satisfaction with the operation and improved post-surgical 
recovery and pain scores. More recently, novel minimally 
invasive techniques have been introduced, including laparo-
endoscopic single-site surgery (LESS),7 natural orifice trans-
luminal endoscopic surgery (NOTES)-assisted laparoscopy,8,9 
mini-laparoscopy,10 and robot-assisted laparoscopy,11 all of 
which have been applied to living donor surgery. 
With surgical technologies advancing towards less inva-
sive methods and with increasing pressure from patients to 
incorporate these new techniques into practice, data has 
emerged suggesting that single-incision surgery may be the 
next major advance to the living donor operation. In a recent 
systematic review and meta-analysis of over 1500 cases 
comparing laparoscopic and LESS nephrectomy, Autorino 
et al12-14 showed that LESS patients benefited from decreased 
postoperative pain, lower analgesic requirements, shorter 
hospital stay, faster recovery time, and not surprisingly, a bet-
ter cosmetic outcome. As we want to minimize the burden of 
living donor surgery to the healthy, young, active individual, 
the concept of minimizing the skin incision is appealing and 
may further incentivize organ donation. 
The learning curve of LESS donor nephrectomy proce-
dure is notoriously steep, even in experienced centres. We 
predicted that the use of robotic assistance would make a 
significant impact on the learning curve of the LESS surgery, 
as it offers a significant improvement in visualization and 
intracorporeal maneuverability and dexterity. Therefore, we 
hypothesized that robotic-assisted LESS living donor surgery 
CUAJ • November 2018 • Volume 12, Issue 11 E441
laparoendoscopic single-site vs. standard living donor nephrectomy
(R-LESS) is feasible, with minimal impact on operative time 
and complications. Furthermore, we evaluated whether 
R-LESS has a positive impact on patient outcomes, pain, 
and quality of life following living donation. 
Methods
Between October 2013 and November 2015, 46 patients 
underwent LDN at University Hospital, London Health 
Sciences Centre, London, ON, Canada. Consecutive patients 
were approached at the time of their first clinic assessment 
to be entered into the prospective study (REB#101769). All 
patients were consented to receive either standard laparo-
scopic donor nephrectomy or R-LESS nephrectomy; ran-
domization was not possible, as access to the robot was 
not predictable. All donor surgeries were performed by 
two surgeons (Patrick Luke, Alp Sener). One surgeon had 
experience with R-LESS pyeloplasty, nephrectomy, partial 
nephrectomy, and adrenalectomy prior to performing donor 
nephrectomy. The donors were slotted for a standing date; if 
the robot was available that day, the patient was placed in 
the R-LESS arm; if the robot was not available, the patient 
was slotted for the LLDN arm of the study. Seven patients 
decided not to participate. Patients underwent either stan-
dard laparoscopic living donor nephrectomy (LLDN) (n=25) 
or R-LESS LDN (n=14). Donor and recipient demographic 
characteristics were collected, including: age, gender, body 
mass index (BMI), side of procedure, and number of renal 
arteries. Perioperative outcomes between the two procedures 
were compared using operative time, warm ischemia time 
(WIT), estimated blood loss, hospital length of stay, analgesic 
requirements (calculated in terms of hydromorphone equiva-
lents), visual analogue scale15 of pain on postoperative days 
1, 3, 7, and 30. Graft function based on serum creatinine 
and modification of diet in renal disease (MDRD)-based 
estimated glomerular filtration rate (eGFR) measurements on 
day 3 and one year, and a health-related quality of life and 
body image questionnaire16 
were also performed on days 
3, 7, and 30 post-donation. 
Delayed graft function (DGF) 
was defined as the need for 
hemodialysis in the first week 
following transplantation. 
Postoperative complications 
were graded according to the 
Clavien-Dindo system.17
Donor nephrectomy surgical technique
Robot-assisted laparoendoscopic single-site technique
The da Vinci Si Surgical System (Intuitive Surgical, Sunnyvale 
CA, U.S.) was used for all procedures. Patients were posi-
tioned in the right lateral decubitus position. A single inci-
sion was made through the umbilicus measuring approxi-
mately 4.0 cm in length and a GelPort (Applied Medical, 
Rancho Santa Margarita, CA, U.S.) pre-punctured with four 
trocars (camera port, two 8 mm robot working trocars, and a 
10 mm accessory trocar) was placed through the umbilicus 
(Fig. 1). Once the abdomen was insufflated, the daVinci 
robot was docked behind the shoulder of the patient with 
the first setup joint locked in a straight position in order 
to facilitate proper insertion of the working instruments as 
previously described (Fig. 2).18 
The operation began with mobilization of the descend-
ing colon. The ureter was then identified and circumferen-
tially dissected along the gonadal vein. Following the left 
gonadal in the cephalad direction, the left renal vein was 
subsequently identified. Gerota’s fascia was incised and the 
kidney was separated from its attachments to the left adrenal 
gland and the spleen. The renal vein was circumferentially 
dissected. The gonadal vein was divided close to the renal 
vein between clips. The left renal artery was circumferen-
tially isolated to the level of its aortic takeoff. The robot was 
then undocked and the ureter was divided using 10 mm 
Hemolock clips. After replacing the 10 mm port with a 15 
mm port (Ethicon Endosurgery, Cincinnati OH, U.S.), the 
renal artery and vein sequentially controlled and stapled 
using a 35 mm endovascular stapler (Ethicon, Cincinnati 
OH, U.S.). 
The kidney was then retrieved with a 15 cm Endocatch 
bag (Ethicon Endosurgery, Cincinnati OH, U.S.) placed 
through the 15 mm port and retrieved through the GelPort. 
The kidney was immediately flushed with Custodiol HTK 
Fig. 1. (A) Placement of inner phalange using GelPort device. (B) Disposable and 8 mm robotic ports placed through the 
GelPort device.
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solution (Odyssey pharmaceuticals Inc., Florham Park, NJ, 
U.S.) containing 10 000 IU of heparin until the effluent was 
clear and placed on ice until transplantation.
Standard multi-port LDN
 A standard LDN was carried out in the usual fashion.18 Once 
the patient was positioned in the manner described above, a 
Hasson blunt tipped trochar was inserted under direct vision 
just lateral and superior to the umbilicus; this was used as 
the camera port. Once the abdomen was insufflated, a 5 mm 
trochar below the costal margin and a 10–12 mm trochar 
was inserted in the lower quadrant. Standard instruments 
were used in all cases. At the point of organ extraction, 
we made a Pfannenstiel incision and introduced a 15 mm 
Endocatch bag for the retrieval, which was done in a similar 
fashion as described above. 
In both groups, WIT was defined as the time between 
initial stapler application to the renal artery and hypothermic 
organ perfusion with preservation solution. 
Statistical analyses
Demographic characteristics, as well as perioperative and 
postoperative outcomes were compared between each of 
the two groups. Complications were classified according to 
the Clavien-Dindo system. Internal reliability for each scale 
was evaluated by Cronbach’s alpha. The Cronbach’s alpha 
for the body image scale was 0.82 and Cronbach’s alpha for 
the Cosmetic questionnaire was 0.76. These values suggest 
that the scales showed good internal consistency. Mean scale 
scores for the of each scale at day 1, 3, 7, and 30 postop-
eratively were evaluated for significance of difference using 
the non-parametric Wilcoxon signed-rank test for hypothesis 
testing of repeated measurements. The categorical data for 
assessing differences in both R-LESS LDN group and LLDN 
group were analyzed using a paired Student’s t-test. Data 
analyses were performed using SPSS version 22.0 (SPSS, 
Inc. Chicago, IL, U.S.).
Results 
The demographic characteristics, intraoperative and post-
operative outcomes for patients in both cohorts are listed 
in Tables 1 and 2. There were no significant differences in 
intraoperative outcomes, including operative time between 
LLDN and R-LESS LDN. Although there were no conver-
sions of R-LESS to LLDN or open DN, the addition of a 5 
mm port was required via the GelPort to facilitate R-LESS 
in four cases where the spleen retraction was difficult. We 
observed no DGF in both group and no statistical differences 
in the mean serum creatinine of the recipients at one year 
post-transplant. Mean creatinine of donors was equivalent 
at day 3 in both cohorts. The R-LESS cohort had statistically 
superior visual pain scores on day 1 and 3 (p<0.001) and the 
mean hydromorphone equivalent analgesia needed in the 
R-LESS cohort was 15.9±3.3 mg in first 48 hours after surgery 
compared to 18.15±5.1 mg for the LLDN cohort (p=0.002).
In the R-LESS LDN group, one patient developed a ret-
roperitoneal hematoma that was treated conservatively and 
transfused with two units of packed red blood cells. In the 
LLDN group, two patients developed abdominal wall hema-
Fig. 2. (A) Positioning of the robot over the posterior shoulder of the patient for single-incision surgery. The patient is positioned at 45 degrees in the right lateral 
oblique position. (B) The first setup joint is locked in a straight position to facilitate proper insertion of multiple working instruments in the umbilical port. Rendering 
© Intuitive Surgical 2015 with permission.
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tomas (managed conservatively), two patients developed 
neuromuscular pain with bilateral flank discomfort, and one 
patient with a BMI of 38 developed a port site infection. 
Overall, postoperative complication rates between the two 
cohorts were low, with all complications classified as Grade 
2 according to the Clavien-Dindo system.
All 14 patients who underwent R-LESS LDN and all 25 
who underwent LLDN responded to The Body Image Scale, 
Cosmesis Scale, and Visual Analog Pain Scale question-
naires. The responses are shown in Tables 3–7.
Body image and cosmesis following living donation
The first question asked of the donors was, “Are you less 
satisfied with your body since the operation?” In the R-LESS 
group, 92% of respondents reported complete satisfaction 
by day 3, whereas only 50% of respondents in the laparo-
scopic group reported complete satisfaction by the third 
day (p=0.002). Although this persisted up to seven days, by 
postoperative day 30, both groups had similar satisfaction 
scores (p=0.71) (Table 3). In response to second question, 
“Do you think the operation has damaged your body?” on 
days 3 and 7, patients undergoing R-LESS felt they had no or 
little damage to their body compared to laparoscopic group 
(p<0.001), but by day 30, both groups reported similar find-
ings (p=0.51) (Table 4). The final question in the body image 
index was, “Is it difficult to look at yourself naked as a result 
of the operation?” Both groups reported similar responses 
to this question at all-time points on postoperative days 3, 
7 and 30, respectively (p=0.41) (Table 5). With respect to 
cosmesis, patients were asked to rate their satisfaction with 
their surgical scar on a scale from 1–7. Cosmetically, living 
donors were more satisfied with their incisions in the R-LESS 
group compared to the LLDN group across all time points 
on postoperative days 3, 7, and 30. (p=0.008) (Table 6).
Visual analog pain score
Living donors from each cohort were asked how they rated 
their pain on a visual analog pain scale from 1–10 on post-
operative days 1, 3, 7, and 30. The R-LESS cohort had statisti-
cally superior pain scores (none/mild pain R-LESS 50% vs. 
26% LLDN group) on day 1 and 3 (p<0.001); however, from 
day 7 onwards, both groups showed similar perceptions of 
pain and clinically not significant (p=0.16) (Table 7). 
Discussion 
With the increasing number of patients requiring kidney 
transplantation, multiple strategies to increase the number of 
donors, including laparoscopic living donation, have been 
developed. Advancements in laparoscopy have led to the 
Table 1. Demographic characteristics
Type of donor surgery
Laparoscopic R-LESS p
Number of patients 25 14 -
Age, years (range) 50 (26–68) 51(41–64) 0.97
Male: Female 7:18 9:5 -
BMI (kg/m ) 27.1±3.8 25.8±3.4 0.24
Right: Left 5:20 0:14 -
Multiple arteries 4 3 -
Data are presented as mean ± standard deviation. BMI: body mass index. R-LESS: robotic 
laparoendoscopic single-site.
Table 2. Intraoperative and postoperative outcomes in 
patients undergoing laparoscopic vs. robot-assisted LESS 
donor nephrectomy
Type of donor surgery
Laparoscopic R-LESS p
Number of patients 25 14 -
Operative time (min) 240±53 269±75 0.90
Estimated blood loss (mL) 103±70 140±59 0.24
Length of stay (days) 3.5± 0.86 3.1±0.70 0.81
WIT (min) 4.15±1.1 4.3±1.1 0.52
Total hydromorphone equivalent 
(mg)
18.15±5.1 15.9±3.3 0.002
Serum creatinine (μmol/L, day 3) 96±10 95±15 0.51
Serum creatinine (μmol/L, 1 
year)
102±21 106±12 0.22
eGFR (mL/min per 1.73 m2) 84±17.14 86±17.74 0.51
DGF 0 0 -
Complications: (Clavien-Dindo) 
Hematoma requiring 
transfusion 
0 1 -
Abdominal wall hematoma no 
transfusion
1 0 -
Neuromuscular pain 2 0 -
Port site infection 1 0 -
All complications classified as Grade 2 according to the Clavien-Dindo system. Data are 
presented as mean ± standard deviation. DGF: delayed graft function; eGFR: estimated 
glomerular filtration rate; R-LESS: robotic laparoendoscopic single-site; WIT: warm ischemic 
time.
Table 3. Body image scale – Are you less satisfied with your 
body since the operation?
Postoperative day
3 7 30
LESS robotic Yes, extremely
Quite a bit
A little bit
No, not at all
0%
0%
8%
92%
0%
8%
34%
58%
8%
0%
34%
58%
Laparoscopic Yes, extremely
Quite a bit
A little bit
No, not at all
0%
0%
50%
50%
4%
4%
35%
57%
0%
0%
26%
74%
R-LESS group, 92% of respondents reported complete satisfaction by day 3, whereas only 
50% of respondents in the LLDN group reported complete satisfaction by the third day 
(p=0.002), but by day 7 and 30, both groups had similar satisfaction scores (p=0.71). LLDN: 
laparoscopic living donor nephrectomy; R-LESS: robotic laparoendoscopic single-site.
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use of LESS surgery in living donation; unfortunately, the 
ergonomics of single-port surgery lends itself to a very steep 
learning curve. The current study was designed to evalu-
ate whether a single-incision robotic platform would allow 
surgeons to make the leap to single-incision living donor 
surgery. We are the first to demonstrate that there were no 
significant differences in intraoperative outcomes between 
LLDN and R-LESS-LDN cohorts. Analysis showed statistically 
differences in visual analogue pain scores on days 1 and 3 
(p<0.001) between the R-LESS LDN and LLDN cohorts, how-
ever, from day 7 onwards, both groups showed similar and 
clinically non-significant perceptions of pain (p=0.16). In 
addition, the analgesic requirements were lower for R-LESS 
cohort (p=0.002) immediately after surgery. They demon-
strate earlier improvement in the donor body image and 
patients in the R-LESS LDN cohort had a higher satisfaction 
score compared to the LLDN cohort (p=0.008). There were 
no significant differences in the postoperative complication 
rates in either cohort.
Gill et al7 first reported the successful completion of four 
single-port transumbilical LDNs. Soon after, the same group 
reported the first retrospective matched-pair comparison 
of LESS LDN to standard LDN, concluding that the LESS 
approach may be associated with quicker convalescence 
and comparable early allograft outcomes.19 Since then, 
other groups have reported comparative assessments of the 
two LDN approaches, with conflicting findings.20-22 When 
adopting a novel surgical technique, patient safety repre-
sents a key factor and this is especially true in the case 
of a LDN. As a general principle, all eligible laparoscopic 
surgery patients may be considered for LESS. At the same 
time, patient selection with LESS must be more rigorous to 
minimize the surgical risk. 
In our study, we found no significant differences in total 
operating time between R-LESS LDN, including robot setup 
time compared with LLDN (p=0.90). Operating time is 
routinely considered a parameter to estimate the surgical 
learning curve. In this regard, Stamatakis et al23 observed 
a little change over the course of their series, suggesting a 
very shallow learning curve and that for a surgeon already 
experienced with LDN, LESS LDN case numbers might not 
be as important in determining operating times after a pla-
teau has been reached. Both surgeons in our cohort have 
extensive expertise in laparoscopic surgery, with one having 
experience in R-LESS surgery, mainly with pyeloplasty.18 The 
Table 4. Body image scale – Do you think the operation has 
damaged your body?
Postoperative day
3 7 30
LESS robotic Yes, extremely
Quite a bit
A little bit
No, not at all
0%
0%
33%
67%
0%
0%
42%
58%
0%
0%
36%
64%
Laparoscopic Yes, extremely
Quite a bit
A little bit
No, not at all
0%
13%
48%
39%
0%
0%
46%
54%
0%
0%
30%
70%
R-LESS group reported no perception of damage to their body on day 3 and 7 compared 
to LLDN group (p=0.001); however, by day 30, both groups reported similar perception 
(p=0.51). LLDN: laparoscopic living donor nephrectomy; R-LESS: robotic laparoendoscopic 
single-site.
Table 5. Body image scale – Is it difficult to look at yourself 
naked as a result of the operation?
Postoperative day
3 7 30
LESS robotic Yes, extremely
Quite a bit
A little bit
No, not at all
0%
0%
18%
82%
0%
4%
7%
89%
0%
0%
0%
100%
Laparoscopic Yes, extremely
Quite a bit
A little bit
No, not at all
0%
4%
7%
89%
0%
0%
8%
92%
0%
0%
13%
87%
Both groups reported similar responses to this question at all-time points on postoperative 
days 3, 7, and 30, respectively (p=0.41). LESS: laparoendoscopic single-site.
Table 6. Cosmesis scale – On a scale of 1–7, how satisfied 
are you with your scar?
Postoperative day
3 7 30
LESS robotic 1, Very unsatisfied
2
3
4
5
6
7, Very satisfied
0%
0%
0%
0%
23%
23%
54%
8%
0%
0%
17%
17%
8%
50%
9%
0%
9%
9%
18%
0%
55%
Laparoscopic 1, Very unsatisfied
2
3
4
5
6
7, Very satisfied
0%
0%
4%
31%
11%
27%
27%
0%
12%
4%
24%
24%
0%
36%
4%
0%
0%
13%
17%
31%
35%
R-LESS group were more satisfied with the cosmetic outcome of the surgery compared 
to the LLDN group on postoperative days 3, 7, and 30 (p=0.008). LLDN: laparoscopic living 
donor nephrectomy; R-LESS: robotic laparoendoscopic single-site.
Table 7. Visual analog pain scale
Postoperative day
1 3 7 30
LESS robotic None (0)
Mild (1–3)
Moderate (4–6)
Severe (7–10)
7%
43%
35%
14%
7%
43%
33%
14%
50%
41%
8%
0%
67%
33%
0%
0%
Laparoscopic None (0)
Mild (1–3)
Moderate (4–6)
Severe (7–10)
4%
22%
52%
22%
0%
59%
26%
15%
38%
47%
15%
0%
64%
36%
0%
0%
R-LESS group reported lower pain scores (none/mild pain R-LESS 50% vs. 26% LLDN 
group) on day 1 and 3 (p<0.001); however, from day 7 onwards, both groups showed 
similar perceptions of pain (p=0.16). LLDN: laparoscopic living donor nephrectomy; R-LESS: 
robotic laparoendoscopic single-site.
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experience provided safety for donor, but limiting ability to 
assess learning curve for R-LESS. 
WIT is traditionally recognized as a surrogate measure of 
surgical quality during LDN.24 We did not find a significant 
difference in WIT between the two cohorts (p=0.52). In their 
comparative studies, Canes et al19 found WIT to be twice 
as long in the LESS LDN group, and most of this extra time 
was spent creating an adequate fascial incision, as this site 
was not prepared before extraction. In contrast, Stamatakis 
et al23 were the first to document a statistically significant 
decrease (0.5 minutes) in WIT with LESS LDN as compared 
with LDN. The authors attributed this finding to the use of 
the GelPoint™, eliminating the need to complete an incision 
after transection of the renal vasculature. Our technique of 
using the GelPort for access allowed for a larger facial inci-
sion, which enabled quick extraction of the kidney while still 
maintaining a smaller skin incision through the umbilicus. 
More clinically relevant than WIT is graft function, which 
was assessed only in few of the studies by using creatinine 
levels.19,20 In the present study, we demonstrate that serum 
creatinine and eGFR levels were similar between the two 
groups (p=0.51), even at one year post-transplant. In addi-
tion, we found no DGF in either group, which is a strong 
predictor of early graft injury and poor longer-term func-
tion,25 thus further supporting that the R-LESS approach to 
living donation does not compromise graft outcomes.
It is a well-established principle that single renal artery 
left kidneys are preferred by most transplant surgeons due 
to the longer length of the left renal vein compared with 
the right renal vein. In the present study, all of the R-LESS 
group had left-sided nephrectomies. We did not exclude 
right donor nephrectomy intentionally. More importantly, 
we had selected the left side despite supernumery arteries 
even before the case was assigned to the R-LESS cohort, 
suggesting that multiple vessels can also be handled with 
the R-LESS approach and that these patients should not be 
excluded. In other reported studies, some investigators con-
sidered only left-sided donors19,21 and non-complex vascu-
lature21,26 as inclusion criteria for LESS donation, whereas 
others did not.20,21 As excellent long-term outcomes can 
be obtained with LDN with right and/or complex vascular 
anatomy requiring reconstruction, the presence of multiple 
renal arteries should ideally not preclude R-LESS kidney 
donation,25 at least in experienced centThe rationale behind 
the adoption of LESS is mainly based on the potential gain 
for the patient in terms of lower postoperative pain, shorter 
hospital stay, and ultimately faster recovery. Length of stay 
represents an unreliable endpoint in this patient population, 
as donors may express the desire to remain in the hospital 
longer because of psychosocial considerations.12 In the pres-
ent study, analysis showed statistically differences in visual 
analogue pain scores on day 1 and 3 (p<0.001) between 
the R-LESS LDN and LLDN cohorts, as well as in analgesic 
requirements; however, from day 7 onwards, both groups 
showed similar and clinically non-significant perceptions of 
pain (p=0.16). They demonstrate earlier improvement in the 
donor body image and the R-LESS LDN cohort had a high 
satisfaction score compared to the LLDN cohort (p=0.008). 
However, there was no significant difference of the hospi-
tal stay between R-LESS LDN and with LLDN (p=0.81). In 
keeping with our findings, Fan et al12 also reported reduced 
postoperative pain and lower analgesic requirement for LESS 
nephrectomy procedures. This is in congruence with what 
we observed and is expected with smaller total length of 
incisions in the R-LESS cohort.
Complication rates are broadly considered surrogate 
markers for surgical complexity. Accurate reporting of com-
plications is important for preoperative counselling and for 
identifying modifiable risk factors to decrease complication 
rates. Greco et al27 investigated risk factors for complica-
tions in a multi-institutional series of LESS surgery for a 
range of upper urinary tract disease and found an overall 
complication rate of 17%. In a larger analysis of surgical 
outcomes from LESS cases of mixed indications, Autorino 
et al28 reported a 9.4% postoperative overall complication 
rate, most of them being of low Calvien grade. In the pres-
ent analysis, we did not find any significant difference in 
terms of postoperative complication rates between the two 
cohorts, with all complications being Grade 2 according to 
the Clavien-Dindo classification.
Although not randomized, this is the first detailed pro-
spective assessment of the R-LESS technique in performing 
LDN. Although our numbers are small, we publish these 
results as an indicator of quality for our novel technique and 
demonstrate modest but significant benefits in this popula-
tion of young, healthy patients, who may engender benefit 
from a cosmetically superior operation. A limitation was 
that we were not able to blind the patients immediately 
preoperatively or postoperatively (with abdominal binders 
to mask the scars); this may be what is needed to truly cre-
ate a randomized trial in the future. However, we did not 
emphasize that one technique was more beneficial than 
the other during the consent process, so as to minimize 
patient bias. It has been our hope that the minimally inva-
sive nature of this technique would increase the appetite 
for healthy, active individuals to participate in living dona-
tion. In fact, it is of interest that the availability of R-LESS 
technique has been associated with an increased interest 
in living donation by potential donor patients at our institu-
tion. Furthermore, we hope that our excellent preliminary 
results will encourage other groups to assess R-LESS donor 
nephrectomy as a part of multicentred, prospective study 
to firmly establish the procedure as a reasonable option 
for donor nephrectomy. With the advancement of robotic 
platforms intended for single-incision surgery by compa-
nies such as Titan MedicalTM and Intuitive Surgical®, the 
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role of robotic surgery in donor nephrectomy should be 
re-assessed on a continuous basis. 
Conclusion
These are the first reported results demonstrating that R-LESS 
LDN procedure offers comparable surgical and early func-
tional outcomes compared to standard LDN but with reduced 
postoperative pain, improved body image scores, and over-
all satisfaction with the donation process. R-LESS is more 
technically challenging than standard LLDN counterpart. 
However, with increasing level of expertise in users across 
many centres and the continually advancing technology 
in robotics, this novel approach should be compared with 
standard LLDN in a well-designed, large, prospective, ran-
domized, ulticenter study before gaining wider acceptance.
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